EU needs to modify existing guidance for nanotech risk assessment
This article was originally published in Clinica
Executive Summary
Modifications to the existing EU technical guidance for the risk assessment of chemicals will be necessary for nanomaterials, including those used in medical technology. That is the view of the EU's Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR), which has just published a scientific opinion on the appropriateness of the EU Technical Guidance Documents for chemicals in regard to nanomaterials.